BioInvent International AB

BioInvent International AB is a biopharmaceutical company based in Lund, Sweden, specialising in Contract Manufacturing (CMO) and Contract Development and Manufacturing (CDMO) services. The company offers extensive expertise in developing processes and producing materials for clinical trials. BioInvent's state-of-the-art GMP facility is equipped with 200 and 1000L single-use bioreactors, enabling efficient production capabilities. Their well-established platform for monoclonal antibodies guarantees rapid process development, production, and regulatory filing, covering aspects from cell line development to QP release for clinical trials.

Services include:
- Contract Development and Manufacturing Organization (CDMO) services
- Contract Manufacturing Organisation (CMO) services
- Monoclonal antibodies production
- Cell line development, including a royalty-free GS knocked CHO K1 cell line
- Process and formulation development
- Analytical development
- Quality assurance and QP release for clinical trials

BioInvent International AB prides itself on its highly experienced team, which offers flexibility and a collaborative approach to achieve clients' goals. For more information, visit bioinvent.com.